Niketa Chotai

Dr. Niketa Chotai

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
NCNiketa Chotai
Niketa Chotai
STSerene Tang
Serene Tang
HLHollie Lim
Hollie Lim
SLSarah Lu
Sarah Lu

24 September 2021 in World Journal of Clinical Oncology
Verified
Journal Article
Open access
TITay Wei Ming Ian
Tay Wei Ming Ian
ETErn Yu Tan
Ern Yu Tan
NCNiketa Chotai
Niketa Chotai
Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients

1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
NCNiketa Chotai
Niketa Chotai
RRRupa Renganathan
Rupa Renganathan
TUTakayoshi Uematsu
Takayoshi Uematsu
JWJane Wang
Jane Wang
QZQingli Zhu
Qingli Zhu
JCJung Min Chang
Jung Min Chang
Chotai N, et al. Korean J Radiol. 2025 Aug;26(8):743-758. https://doi.org/10.3348/kjr.2025.0338

24 March 2022 in The Breast Journal
Verified
Journal Article
Open access
PDF file
ALAmanda Ling Fung Liew
Amanda Ling Fung Liew
HLHollie Mei Yeen Lim
Hollie Mei Yeen Lim
EFElizabeth Chun Mei Fok
Elizabeth Chun Mei Fok
SLSiu Cheng Loke
Siu Cheng Loke
ETErn yu Tan
Ern yu Tan
NCNiketa Chotai
Niketa Chotai
Objectives. To evaluate the potential of contrast-enhanced spectral mammography (CESM) in reducing benign breast biopsy rate, thereby improving resource utilization. To explore its potential as a value-adding modality in the management of BI-RADS 4/5 lesions. Materials and Methods. This was a prospective study conducted between July 2016 and September 2018. Patients with BI-RADS 4/5 lesions detected on conventional imaging (mammogram, digital breast tomosynthesis, and ultrasound) were enrolled for adjunct CESM. Histopathologic correlation was done for all lesions. Additional suspicious lesions detected on CESM were all identified on second-look ultrasound and subsequently biopsied. Images were evaluated independently by two radiologists trained in breast imaging using BI-RADS classification. Presence of enhancement on CESM, BI-RADS score, and histopathology of each lesion were analyzed and tested with the chi-square/fisher-exact test for statistical significance. Results. The study included 105 lesions in 63 participants—1 man and 62 women, an average age of 53.7 ± 10.8 years. On CESM, 22 (20.9%) of the lesions did not show enhancement. All 22 lesions had been classified as BI-RADS 4A and were subsequently proven to be benign. Of the remaining 83 enhancing lesions, 54 (65.1%) were malignant and 29 (34.9%) were benign ( ). CESM detected 6 additional lesions which were not identified on initial conventional imaging. Four of these were proven malignant and were in a different quadrant than the primary lesion investigated. Conclusion. There is evidence that the absence of enhancement in CESM strongly favors benignity. It may provide the reporting radiologist with greater confidence in imaging assessment, especially in BI-RADS 4A cases, where a proportion of them are in actuality BI-RADS 3. Greater accuracy of BI-RADS grading can reduce nearly half of benign biopsies and allow better resource allocation. CESM also increases the detection rate of potentially malignant lesions, thereby changing the treatment strategies.

16 August 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
NCNiketa Chotai
Niketa Chotai
KPKathleen Ann Pang
Kathleen Ann Pang
JLJoon Wei Lim
Joon Wei Lim
With the increasing use of MRI in clinical practice, the need for MRI-guided intervention is also increasing. Indeterminate lesions identified on MRI without mammographic or sonographic correlates will need to be approached under MRI guidance. MRI-guided biopsy is a skill that can be acquired with proper training and guidance. These procedures have their own set of challenges and issues; some of them are specific to the patient habitus in this region. Adequate knowledge and understanding of the challenges can help the radiologist to be better equipped to face these issues and solve them promptly during the procedure, thus increasing the overall success rate of the procedure. Not much local data from Asian countries is available on this front. This paper aims to share common challenges one may face while performing MRI-guided biopsy and share some tips and tricks to address these problems. Hopefully, this will help the readers achieve a higher success rate for MRI-guided interventions in their clinical practice.

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
RKRenuka Nair Kunju Krisnan
Renuka Nair Kunju Krisnan
NCNiketa Chotai
Niketa Chotai
Krisnan RN, et al. Korean J Radiol. 2021 Apr;22:e46. https://doi.org/10.3348/kjr.2020.0779